Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

医学 楔形切除术 腺癌 肺癌 外科 内科学 癌症 切除术
作者
Di Li,Chaoqiang Deng,Shengping Wang,Yuan Li,Yang Zhang,Haiquan Chen
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [Elsevier BV]
卷期号:164 (6): 1614-1622.e1 被引量:17
标识
DOI:10.1016/j.jtcvs.2022.06.017
摘要

Objective This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10-year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1% (41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
CipherSage应助老六采纳,获得10
1秒前
adamwang发布了新的文献求助10
1秒前
研友_Z33zkZ发布了新的文献求助10
1秒前
tokita发布了新的文献求助10
1秒前
Dr2030完成签到,获得积分10
1秒前
SciGPT应助高贵振家采纳,获得10
2秒前
LH发布了新的文献求助10
2秒前
Diffileft发布了新的文献求助10
2秒前
2秒前
2秒前
orixero应助零零柒采纳,获得10
2秒前
DJ发布了新的文献求助10
3秒前
Viikey完成签到,获得积分0
3秒前
蘅芜潇湘发布了新的文献求助10
3秒前
orixero应助研友采纳,获得10
3秒前
怂怂鼠完成签到,获得积分10
3秒前
小沃尔特完成签到 ,获得积分10
4秒前
情怀应助安云野采纳,获得30
4秒前
小恐龙发布了新的文献求助10
4秒前
ztl17523发布了新的文献求助30
4秒前
4秒前
小包子完成签到,获得积分10
5秒前
5秒前
5秒前
Hello应助伶俐芷波采纳,获得10
6秒前
6秒前
6秒前
汉堡包应助科研通管家采纳,获得10
6秒前
秦大帅完成签到,获得积分10
6秒前
大狒狒发布了新的文献求助10
6秒前
丘比特应助科研通管家采纳,获得10
6秒前
xing_xing应助科研通管家采纳,获得20
7秒前
7秒前
DW应助科研通管家采纳,获得10
7秒前
Hello应助科研通管家采纳,获得10
7秒前
汉堡包应助平淡凡柔采纳,获得10
7秒前
所所应助科研通管家采纳,获得10
7秒前
xing_xing应助科研通管家采纳,获得20
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The anomeric effect 1000
Principles of town planning: translating concepts to applications 1000
Navigating Normative Orders: Interdisciplinary Perspectives 750
1 Peter and Christ's Descent to the Dead in Its Early Christian Reception 700
Organizational Behavior 510
Management and the Arts 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7733940
求助须知:如何正确求助?哪些是违规求助? 9284452
关于积分的说明 20165120
捐赠科研通 7311854
什么是DOI,文献DOI怎么找? 3304529
关于科研通互助平台的介绍 2457139
邀请新用户注册赠送积分活动 2313727